The differential responses of MMP1, MMP3, MMP10, MMP12, SPINK4, SERPINA1, and CXCL1 to various drug treatments provide insights into the regulatory mechanisms underlying CRC drug resistance and sensitivity. This evidence concerns the gene MMP10 and colorectal carcinoma.